Thrombotic vascular risk factors in inflammatory bowel disease.

M Hudson, A Chitolie, R A Hutton, M S Smith, R E Pounder, A J Wakefield

University Department of Medicine, Royal Free Hospital School of Medicine, London.

BACKGROUND--Thrombosis may be an important effector mechanism in the pathogenesis of Crohn's disease. METHODS--This study therefore investigated the prevalence of independent thrombotic risk factors (factor VII coagulant activity, lipoprotein (a), fibrinogen, plasma triglycerides, and smoking) in patients with Crohn's disease, ulcerative colitis, and normal controls. RESULTS--In Crohn's disease (n = 75), the mean plasma VII:C, lipoprotein (a) and fibrinogen concentrations were significantly greater than in the normal population (n = 85). In ulcerative colitis (n = 35), only the mean factor VII:C concentration was significantly higher than normal. Ninety three per cent of patients with Crohn's disease and 86% of those with ulcerative colitis had at least one risk factor for thrombotic vascular disease, compared with 61% of the normal population (p < 0.001). CONCLUSIONS--In many young patients with inflammatory bowel disease, plasma concentrations of these prothrombotic factors were in excess of the limits that are regarded as posing an increased risk for the development of occlusive vascular disease.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

• Deban, L., Correale, C., Vetrano, S., Malesci, A., Danese, S. (2008). Multiple Pathogenic Roles of Microvasculature in Inflammatory Bowel Disease: A Jack of All Trades. Am. J. Pathol. 172: 1457-1466 [Abstract] [Full Text]  
• Rahman, M., Thekkudan, J., Ionescu, A., Ashraf, S. (2006). Spontaneous right atrial thrombus in a patient with Crohn's disease: an unusual right atrial mass. ICVTS 5: 664-665 [Abstract] [Full Text]  
• Miehsler, W, Reinisch, W, Valic, E, Osterode, W, Tillinger, W, Feichtenschlager, T, Grisar, J, Machold, K, Scholz, S, Vogelsang, H, Novacek, G (2004). Is inflammatory bowel disease an independent and disease specific risk factor for thromboembolism?. Gut 53: 542-548 [Abstract] [Full Text]  
• Kao, A., Dlugos, D., Hunter, J. V., Mamula, P., Thorarensen, O. (2002). Anticoagulation Therapy in Cerebral Sinovenous Thrombosis and Ulcerative Colitis in Children. J Child Neurol 17: 479-482 [Abstract]  
• Wallace, J. L., Ma, L. (2001). Inflammatory Mediators in Gastrointestinal Defense and Injury. Exp. Biol. Med. 226: 1003-1015 [Abstract] [Full Text]  
• Nackman, G. B., Feuer, D. S., Stefan, T. M., Ciocca, R. G., Graham, A. M. (2000). Phlegmasia Cerulea Dolens in a Patient with Ulcerative Colitis Treated by Iliofemoral Venous Thrombectomy: A Case Report. VASC ENDOVASCULAR SURG 34: 583-589 [Abstract]  
• Mahmud, N, Molloy, A, McPartlin, J, Corbally, R, Whitehead, A S, Scott, J M, Weir, D G (1999). Increased prevalence of methylenetetrahydrofolate reductase C677T variant in patients with inflammatory bowel disease, and its clinical implications. Gut 45: 389-394 [Abstract] [Full Text]